Amedisys Stock In The News

AMED Stock  USD 92.57  0.02  0.02%   
Our overall analysis of Amedisys' news coverage and content from conventional and social sources shows investors' bearish mood towards Amedisys. The specific impact of Amedisys news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Amedisys' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Amedisys headlines in addition to utilizing other, more conventional financial analysis modules. Check out Amedisys Backtesting and Amedisys Hype Analysis.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Amedisys Today Top News and Investor Outlook

Yahoo News
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
https://finance.yahoo.com/news/amed-q4-earnings-revenues-miss-111400849.html
 Bullish
Yahoo News
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
https://finance.yahoo.com/news/amedisys-amed-reports-q4-earnings-020004404.html
 Bullish
Yahoo News
Amedisys (AMED) Lags Q4 Earnings and Revenue Estimates
https://finance.yahoo.com/news/amedisys-amed-lags-q4-earnings-225006650.html
 Bullish
Yahoo News
Amedisys: Q4 Earnings Snapshot
https://finance.yahoo.com/news/amedisys-q4-earnings-snapshot-215509559.html
 Bullish
Macroaxis News: globenewswire.com
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
https://www.globenewswire.com/news-release/2025/02/26/3033394/30555/en/Amedisys-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results.html
 Bullish
Yahoo News
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
https://finance.yahoo.com/news/amedisys-reports-fourth-quarter-end-213000744.html
 Bullish
Yahoo News
DOJ Investigates Medicare Billing Practices at UnitedHealth
https://finance.yahoo.com/m/cb58e65a-8572-3c64-add1-c6c805a21061/doj-investigates-medicare.html
 Bullish
Yahoo News
UnitedHealth Stock Falls on Report DOJ Is Probing Its Medicare Billing Practices
https://finance.yahoo.com/m/596c397c-76da-3f55-a9ef-69e17a92a753/unitedhealth-stock-falls-on.html
 Bullish
Yahoo News
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
https://finance.yahoo.com/news/amedisys-amed-earnings-expected-grow-150052255.html
 Bullish
Macroaxis News: globenewswire.com
Amedisys Honors 47 Employees With Annual Spirit of Excellence Award
https://www.globenewswire.com/news-release/2025/02/03/3019332/30555/en/Amedisys-Honors-47-Employees-With-Annual-Spirit-of-Excellence-Award.html
 Bullish

Amedisys Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Amedisys and other traded companies coverage with news coverage. We help investors stay connected with Amedisys headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Amedisys Stock performance. Please note that trading solely based on the Amedisys hype is not for everyone as timely availability and quick action are needed to avoid losses.
Amedisys' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Amedisys investors visualize upcoming and past events in order to time the market based on Amedisys noise-free hype analysis.
Amedisys stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Amedisys earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Amedisys that are available to investors today. That information is available publicly through Amedisys media outlets and privately through word of mouth or via Amedisys internal channels. However, regardless of the origin, that massive amount of Amedisys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amedisys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amedisys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amedisys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amedisys alpha.

Amedisys Largest EPS Surprises

Earnings surprises can significantly impact Amedisys' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2003-05-13
2003-03-310.080.090.0112 
2002-11-11
2002-09-300.080.10.0225 
2014-05-08
2014-03-31-0.04-0.07-0.0375 
2012-08-07
2012-06-300.240.270.0312 
2003-08-12
2003-06-300.090.120.0333 
2002-08-07
2002-06-300.160.13-0.0318 
View All Earnings Estimates

Amedisys Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Amedisys Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
13th of March 2025
Acquisition by Nick Muscato of 5832 shares of Amedisys subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
6th of March 2025
Amedisys chief accounting officer sells 187,833 in stock - Investing.com India
at news.google.com 
zacks News
3rd of March 2025
AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises
at zacks.com 
zacks News
27th of February 2025
Amedisys Reports Q4 Earnings What Key Metrics Have to Say
at zacks.com 
Yahoo News
26th of February 2025
Amedisys Q4 Earnings Snapshot
at finance.yahoo.com 
news
24th of February 2025
Amedisys, Inc. Shares Acquired by South Dakota Investment Council
at thelincolnianonline.com 
Yahoo News
21st of February 2025
UnitedHealth sinks on WSJ report of DoJ launching probe into Medicare practices
at finance.yahoo.com 
Google News at Macroaxis
6th of February 2025
FY2026 EPS Estimates for Amedisys Raised by Leerink Partnrs - MarketBeat
at news.google.com 
news
27th of December 2024
UnitedHealth, Amedisys waive right to terminate merger pact UNHAMED
at thefly.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Amedisys Backtesting and Amedisys Hype Analysis.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.35)
Earnings Share
1.31
Revenue Per Share
71.775
Quarterly Revenue Growth
0.048
Return On Assets
0.0624
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.